BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36966430)

  • 1. Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis.
    Sariyildiz A; Coskun Benlidayi I; Turk I; Zengin Acemoglu SS; Unal I
    Rheumatol Int; 2023 May; 43(5):923-932. PubMed ID: 36966430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
    Kilic G; Kilic E; Ozgocmen S
    Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between central sensitization and disease activity, quality of life, and sleep quality among patients with axial spondyloarthritis.
    Aykurt Karlıbel I; Kasapoğlu Aksoy M
    Ir J Med Sci; 2023 Feb; 192(1):481-489. PubMed ID: 35226249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.
    Di Carlo M; Lato V; Carotti M; Salaffi F
    Health Qual Life Outcomes; 2016 May; 14():78. PubMed ID: 27188166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis.
    Baysal O; Durmuş B; Ersoy Y; Altay Z; Senel K; Nas K; Uğur M; Kaya A; Gür A; Erdal A; Ardıçoğlu O; Tekeoğlu I; Cevik R; Yıldırım K; Kamanlı A; Saraç AJ; Karatay S; Ozgocmen S
    Rheumatol Int; 2011 Jun; 31(6):795-800. PubMed ID: 20221605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
    Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
    Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning.
    Yılmaz O; Tutoğlu A; Garip Y; Ozcan E; Bodur H
    Rheumatol Int; 2013 May; 33(5):1159-63. PubMed ID: 22955799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
    Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the clinical characteristics and quality of life of male and female patients with non-radiographic axial spondyloarthritis.
    Unal Enginar A
    Int Immunopharmacol; 2023 Oct; 123():110627. PubMed ID: 37494835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity and reliability of quality of life questionnaires in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and meta-analysis.
    He Q; Luo J; Chen J; Yang J; Yao C; Xu C; Tao Q
    Health Qual Life Outcomes; 2022 Jul; 20(1):116. PubMed ID: 35907948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
    Kilic G; Kilic E; Ozgocmen S
    Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
    Michielsens C; Bolhuis TE; van Gaalen FA; van den Hoogen F; Verhoef LM; den Broeder N; den Broeder AA
    Scand J Rheumatol; 2024 May; 53(3):180-187. PubMed ID: 37339375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis.
    Gao R
    J Musculoskelet Neuronal Interact; 2021 Sep; 21(3):440-446. PubMed ID: 34465685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread pain in axial spondyloarthritis: clinical importance and gender differences.
    Swinnen TW; Westhovens R; Dankaerts W; de Vlam K
    Arthritis Res Ther; 2018 Jul; 20(1):156. PubMed ID: 30053895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and related variables in patients with ankylosing spondylitis.
    Bodur H; Ataman S; Rezvani A; Buğdaycı DS; Cevik R; Birtane M; Akıncı A; Altay Z; Günaydın R; Yener M; Koçyiğit H; Duruöz T; Yazgan P; Cakar E; Aydın G; Hepgüler S; Altan L; Kırnap M; Olmez N; Soydemir R; Kozanoğlu E; Bal A; Sivrioğlu K; Karkucak M; Günendi Z
    Qual Life Res; 2011 May; 20(4):543-9. PubMed ID: 20978859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.
    Sunar I; Ataman S; Nas K; Kilic E; Sargin B; Kasman SA; Alkan H; Sahin N; Cengiz G; Cuzdan N; Gezer IA; Keskin D; Mülkoğlu C; Resorlu H; Bal A; Duruöz MT; Küçükakkaş O; Yurdakul OV; Melikoglu MA; Aydın Y; Ayhan FF; Bodur H; Calis M; Capkın E; Devrimsel G; Gok K; Hizmetli S; Kamanlı A; Keskin Y; Kocabas H; Kutluk O; Şen N; Şendur OF; Tekeoğlu I; Tolu S; Toprak M; Tuncer T
    Rheumatol Int; 2020 Feb; 40(2):283-294. PubMed ID: 31773391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?
    Maksymowych WP; Inman RD; Bessette L; Rahman P; Rampakakis E; Asin-Milan O; Rachich M; Marrache AM; Lehman AJ
    Arthritis Res Ther; 2023 Apr; 25(1):70. PubMed ID: 37118833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.